Back to search

France· FR:67562982

FRAGMINE 15 000 U.I. anti-Xa/0,6 mL, solution injectable en seringue pré-remplie

A dalteparin product containing daltéparine sodique, registered in France by PFIZER HOLDING FRANCE, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC B01AB04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedFRAGMINE 15 000 U.I. anti-Xa/0,6 mL, …ATCB01AB04REGISTER NO.FR:67562982PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Dalteparin is registered in 13 of 19 countries.

Countries holding a registration under ATC B01AB04 (dalteparin), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Dalteparin · ATC B01AB04

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
DALTÉPARINE SODIQUE
Manufacturer
PFIZER HOLDING FRANCE
Country
France (FR)
ATC code
B01AB04
ATC class
Dalteparin
Defined daily dose
2.5 TSD, E
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400939743462
    5 seringue(s) préremplie(s) en verre de 0,6 ml avec piston(s) polystyrène avec système de sécurité Needle-Trap avec protège-aiguille caoutchouc
    EUR 36.51

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

203 interactions on record for dalteparin.

Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Dalteparin · interactions on record

203 records

  • 106 severe
  • 73 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe

24 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd6225f4-55dd-454d-89aa-22d48161e95a
GET /v1/drugs/fd6225f4-55dd-454d-89aa-22d48161e95a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "67562982",
  "date_amm": "2010-01-20",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "DALTÉPARINE SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about dalteparin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.